XML 13 R4.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Operating expenses        
General and administrative $ 2,501,206 $ 2,309,149 $ 5,269,072 $ 8,740,862
Research and development 2,120,051 879,843 4,078,765 1,076,487
Depreciation and amortization 85,502 174,019 154,767 310,659
Total operating expenses 4,706,759 3,363,011 9,502,604 10,128,008
Loss from operations (4,706,759) (3,363,011) (9,502,604) (10,128,008)
Other income (expense)        
Inducement expense (298,714)
Change in fair value of warrant liabilities 1,969,922 2,459,543 2,245,891 6,272,543
Change in fair value of derivative liability (53,000) (53,000)
Interest expense (668) (4,821) (4,806) (4,821)
Total other income 1,916,254 2,454,722 2,188,085 5,969,008
Net loss (2,790,505) (908,289) (7,314,519) (4,159,000)
Less preferred dividends attributable to non-controlling interest 7,808 7,808
Less deemed dividends attributable to accretion of embedded derivative at redemption value 73,994 73,994
Net loss attributable to shareholders (2,872,307) (908,289) (7,396,321) (4,159,000)
Other comprehensive gain (loss)        
Foreign currency translation (281,014) (33,262) (192,305) 2,474
Comprehensive loss $ (3,153,321) $ (941,551) $ (7,588,626) $ (4,156,526)
Net loss per share - basic and diluted $ (2.73) $ (2.13) $ (7.78) $ (10.62)
Weighted average shares outstanding, basic and diluted 1,053,760 426,883 951,193 391,516